Market revenue in 2023 | USD 448.9 million |
Market revenue in 2030 | USD 742.6 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the Argentina formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
The country has become an attractive target destination for clinical trial and life science research activities in recent years, owing to its well-organized & developed regulatory environment. The regulation of oversight and approval for clinical trials and drug developments in the country is done by the (ANMAT) National Administration of Drugs, Food, and Medical Technology.
The pharmaceutical companies are widely considering Argentina to conduct clinical research and drug formulation process due to the relatively efficient and quick regulatory processes. In addition, the country has a sizable pool of skilled and well-educated healthcare workforce, which is essential for drug development processes.
With diverse mix of population and socioeconomic background, the country suits the requirement for drug testing activities, therefore shifting the attention of pharma and biotech companies. These factors in turn are increasing the demand for drug formulation development outsourcing activities in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Argentina formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account